COVID-19 vaccines could be available for youngsters as young as 6 months within the US by the fall, Pfizer and Moderna told The New York Times on Tuesday.
Pfizer introduced on Tuesday that it was testing its COVID-19 vaccine in 5- to 12-year-olds. The drugmaker informed The Times that it might doubtless begin testing the shot in kids as young as 6 months within the subsequent few weeks.
Pfizer stated it hoped to be in a position to apply for emergency authorization from the Food and Drug Administration by the fall to manage its vaccine to young youngsters.
Moderna’s CEO, Stéphane Bancel, informed The Times that it could additionally get related FDA authorization by early fall.
“We have to go down in age very slowly and carefully,” Bancel stated.
This is a creating story. Please examine again for updates.
Read the unique article on Business Insider